Breaking News
Top News
-
ICC Moves Ahead With Disciplinary Proceedings Against Chief Prosecutor
-
Stellantis Is Strengthening Its Ties to Palantir. Down 35% YTD, Should You Buy the Dip in STLA Stock?
-
Marmite sold to the Americans in £50bn deal
-
Will Valero’s Refinery Explosion and Closure Have Ripple Effects on Oil Prices?
-
Apple Is the Best-Performing Magnificent 7 Stock in 2026. Should You Buy It for Q2?
-
Eos Energy Director Buys $100,000 in Stock — What Investors Need to Know
-
3 Tech Stocks the Market Sold Off for the Wrong Reasons This Past Month
-
What Correction? 4 Nasdaq Stocks on a Roll That Still Have More Upside
-
BMO Capital Cuts PT on TPG Inc. (TPG) to $48 From $60 – Here’s Why
-
Vertiv Holdings (VRT) Announces Four New or Expanding Manufacturing Facilities in the Americas
-
Truist Initiates Coverage of EQT Corporation (EQT) With a Buy Rating and $74 PT
-
Coeur Mining (CDE) Gets Upgraded to Outperform From Sector Perform by ATB Capital
-
Truist Initiates Coverage of Range Resources Corporation (RRC) With a Hold Rating
-
Why is ONEOK (OKE) One of the Most Profitable NYSE Stocks to Invest In?
-
Wells Fargo Lifts PT on Venture Global (VG) to $14 From $10 – Here’s Why
-
BMO Capital Cuts PT on BioNTech SE (BNTX) to $128 From $143 – Here’s Why
-
ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy Claims in Advertisement
-
Stifel Lifts PT on Insmed Incorporated (INSM) to $208 From $205 – Here’s Why
-
Mizuho Lifts PT on BridgeBio Pharma (BBIO) to $106 From $91 – Here’s Why
-
Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now
2026-02-05


































